Baller Alert
  • Home
    • News
    • Entertainment
    • The Baller Alert Show
    • Baller Alert Lists
    • Baller Alert Exclusives
    • Let Me Liv
    • Ballerific Music
    • That’s Baller
    • Fashion
    • Metaverse
    • Tech
    • Lifestyle
    • Sports
    • Op-Ed
    • Travel
    • Health
  • EVENTS
  • Videos
  • Shop
  • About
  • Political News
  • en español
No Result
View All Result
  • Home
    • News
    • Entertainment
    • The Baller Alert Show
    • Baller Alert Lists
    • Baller Alert Exclusives
    • Let Me Liv
    • Ballerific Music
    • That’s Baller
    • Fashion
    • Metaverse
    • Tech
    • Lifestyle
    • Sports
    • Op-Ed
    • Travel
    • Health
  • EVENTS
  • Videos
  • Shop
  • About
  • Political News
  • en español
No Result
View All Result
Baller Alert
No Result
View All Result

First Alzheimer’s Drug to Slow Disease Gets Full FDA Approval

by Iesha
July 7, 2023
Reading Time: 3 mins read
0
First Alzheimer's Drug to Slow Disease Gets Full FDA Approval

Alzheimers Concept - a conceptual look at Alzheimers disease, and some of the problems it brings.

Share on FacebookShare on Twitter

On Thursday, the U.S. Food and Drug Administration officially approved the Alzheimer’s medication lecanemab, which is sold under the brand name Leqembi.

“Today’s action is the first verification that a drug targeting the underlying disease process of Alzheimer’s disease has shown clinical benefit in this devastating disease,” said the acting director of the Office of Neuroscience in the FDA’s Center for Drug Evaluation and Research, Teresa Buracchio.

Leqembi, created by Eisai and Biogen, is a pioneering medication that targets the fundamental biology of Alzheimer’s disease. It is the first drug to exhibit the ability to slow the advancement of the disease, including cognitive decline and memory loss.

“Today marks a breakthrough in the treatment of Alzheimer’s disease, and we are proud to be at the forefront of ushering in a new era of advances for a disease that was previously considered untreatable,” Biogen president and CEO Christopher A. Viehbacher said in a statement.

He said the company will be “working alongside Eisai with the goal of making [Leqembi] accessible to eligible patients as soon as possible.”

Based on a single mid-stage study of 800 individuals with early-stage Alzheimer’s who were still capable of living independently or with little help, the FDA gave its initial approval for the drug in January.

Later, Eisai released the findings of a larger, 1,800-patient study, which the FDA had evaluated as part of the complete approval procedure.

The larger study monitored patients’ cognitive functions using an 18-point scale and showed a minimal difference of less than half a point after 18 months. This has sparked a debate on whether this small improvement can be considered meaningful.

In the most recent news release, it was announced that the decision reached by the committee was unanimous, with all members voting in agreement that the study results confirmed the drug’s efficacy.

Buracchio noted that “This confirmatory study verified that it is a safe and effective treatment for patients with Alzheimer’s disease.”

“This drug is not a cure. It doesn’t stop people from getting worse, but it does measurably slow the progression of the disease,” said Dr. Joy Snider, a neurologist at Washington University in St. Louis. “That might mean someone could have an extra six months to a year of being able to drive.”

Leqembi has certain downsides, as noted by Snider. These include the need for bi-monthly infusions and potential side effects like brain swelling. The Alzheimer’s Association has also reported infusion-related reactions and headaches as additional side effects.

The drug is estimated to cost around $26,500 for a normal year of treatment, which makes it difficult for many people to afford it.

Chiquita Brooks-Lasure, the leader of the Centers for Medicare and Medicaid Services, made a commitment on Thursday to “cover this medication broadly while continuing to gather data that will help us understand how the drug works” — a decision that will make it more affordable for many. Brooks-Lasure called the FDA’s approval “welcome news for the millions of people in this country and their families who are affected by this debilitating disease.”

Following the initial approval, the FDA called the drug “an important advancement in the ongoing fight to effectively treat Alzheimer’s disease.”

“Alzheimer’s disease immeasurably incapacitates the lives of those who suffer from it and has devastating effects on their loved ones,” said Dr. Billy Dunn, former director of the Office of Neuroscience in the FDA’s Center for Drug Evaluation and Research. “This treatment option is the latest therapy to target and affect the underlying disease process of Alzheimer’s, instead of only treating the symptoms of the disease.”

Share this:

  • Click to share on X (Opens in new window) X
  • Click to share on Facebook (Opens in new window) Facebook
  • Click to share on Mastodon (Opens in new window) Mastodon
  • Click to share on Reddit (Opens in new window) Reddit
  • Click to share on X (Opens in new window) X
  • Click to share on WhatsApp (Opens in new window) WhatsApp
  • Click to share on Tumblr (Opens in new window) Tumblr
  • Click to email a link to a friend (Opens in new window) Email
  • Click to share on Pinterest (Opens in new window) Pinterest

Like this:

Like Loading...

Discover more from Baller Alert

Subscribe to get the latest posts sent to your email.

Related Posts

Bryana Bongolan recounts terrifying moment at Cassie’s L.A. apartment during Diddy's sex trafficking trial
News

“He Lifted Me Over the Balcony!” — Diddy Accused of Nearly Dropping Woman From 17 Floors Up

June 4, 2025

The disturbing details keep pouring out of Sean “Diddy” Combs’ sex trafficking trial, and the latest testimony has left the...

Jessie J - Selfie
News

Jessie J Reveals Early Breast Cancer Diagnosis

June 4, 2025

Jessie J is letting know that she’s been diagnosed with early-stage breast cancer. In a heartfelt Instagram video shared on...

#image_title
News

Texas Man Arrested for Trespassing at Mar-a-Lago, Says He Wanted to Marry Trump’s Granddaughter, Kai

June 4, 2025

A Texas man was taken into custody early Tuesday after allegedly trespassing at Mar-a-Lago, claiming he wanted to “spread the...

Kai Cenat Cancels Stream with Kanye West After Controversial Tweets
News

Kai Cenat Looking To Take Legal Action To Secure Rights to “Streamer University” Before the Imitators Can

June 4, 2025

Kai Cenat isn’t letting anyone run off with his vision. The Twitch star is officially taking legal steps to secure...

Next Post
Blueface Ordered To Pay $13 Million To Vegas Strip Club Following Shooting Incident

Blueface Faces Backlash for Questioning 6-Year-Old Son About His Sexual Orientation [Video]

Leave a ReplyCancel reply

Baller News

Subscribe To Our Newsletter

* indicates required

Follow Us

Subscribe to Blog

Enter your email address to subscribe to this blog and receive notifications of new posts by email.

© Copyright 2024, Baller Alert Inc. All Rights Reserved

No Result
View All Result
  • Home
    • News
    • Entertainment
    • The Baller Alert Show
    • Baller Alert Lists
    • Baller Alert Exclusives
    • Let Me Liv
    • Ballerific Music
    • That’s Baller
    • Fashion
    • Metaverse
    • Tech
    • Lifestyle
    • Sports
    • Op-Ed
    • Travel
    • Health
  • EVENTS
  • Videos
  • Shop
  • About
  • Political News
  • en español
%d